Tipranavir-Ritonavir Genotypic Resistance Score in Protease Inhibitor-Experienced Patients

To identify mutations associated with the virological response (VR) to a tipranavir-ritonavir (TPV/r)-based regimen, 143 patients previously treated with protease inhibitor (PI) were studied. VR was defined by a decrease of at least 1 log(10) in, or undetectable, human immunodeficiency virus (HIV) R...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Marcelin, Anne-Genevieve, Masquelier, Bernard, Descamps, Diane, Izopet, Jacques, Charpentier, Charlotte, Alloui, Chakib, Bouvier-Alias, Magali, Signori-Schmuck, Anne, Montes, Brigitte, Chaix, Marie-Laure, Amiel, Corinne, Santos, Georges Dos, Ruffault, Annick, Barin, Francis, Peytavin, Gilles, Lavignon, Marc, Flandre, Philippe, Calvez, Vincent
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology (ASM) 2008
נושאים:
Antiviral Agents
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2533483/
https://ncbi.nlm.nih.gov/pubmed/18625773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00133-08
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים